Plain-English translation of NCT07037277 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing whether a new medication combination called works as well as an existing hepatitis C treatment called . The trial will enroll about 880 adults with chronic hepatitis C and compare how safe and effective the medication is in treating the virus.
Hepatitis C can be cured with antiviral medications, but researchers are always looking for treatments that may work better, have fewer side effects, or be easier to take. This trial will help determine if the new treatment is a good option for patients.
If you qualify, you will be randomly assigned to take either the new medication combination or the existing treatment. You will take the medication by mouth for a set period of time while the researchers monitor your health with blood tests and visits. The trial will track how well the medication works to clear the hepatitis C virus and check for any side effects.
AI-generated summary from trial data · Jul 8, 2026 · Not medical advice
Egypt
France